ICD-10 Code C90.32 | Solitary plasmacytoma in relapse Symptoms, Diagnosis, Billing

Solitary plasmacytoma in relapse is a localized form of plasma cell neoplasm characterized by the presence of a single tumor of monoclonal plasma cells. This condition is clinically significant as it may indicate progression to multiple myeloma. Accurate coding with ICD-10 Code C90.32 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.

What is ICD-10 Code C90.32 for Solitary plasmacytoma in relapse?

ICD-10 Code C90.32 represents solitary plasmacytoma in relapse, a condition where a previously treated solitary plasmacytoma reoccurs. This code is used in clinical documentation and billing when a patient presents with signs of relapse after initial treatment, allowing for appropriate management and monitoring of the disease.

ICD-10 Code C90.32 – Clinical Definition and Explanation of Solitary plasmacytoma in relapse

Solitary plasmacytoma in relapse occurs when a localized plasma cell tumor reappears after treatment, often indicating a risk for progression to multiple myeloma. This condition requires prompt medical attention to manage symptoms and prevent complications.

Key Clinical Features:

• Localized bone pain or swelling at the site of the tumor.
• Presence of monoclonal protein in serum or urine.
• Radiological evidence of bone lesions or soft tissue masses.
• Potential for systemic symptoms such as fatigue or weight loss.

ICD-10 Code C90.32 for Solitary plasmacytoma in relapse – SOAP Notes & Clinical Use

ICD-10 Code C90.32 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's clinical status and response to therapy.

What Does ICD-10 Code C90.32 for Solitary plasmacytoma in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C90.32 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of solitary plasmacytoma in relapse. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C90.32 – Solitary plasmacytoma in relapse

Management of solitary plasmacytoma in relapse often requires hospitalization for treatment and monitoring. Treatment approaches may include radiation therapy or chemotherapy, depending on the patient's condition.

Antibiotic Therapy:

• Not applicable as solitary plasmacytoma is not infectious.

Supportive Care:

• Pain management with analgesics.
• Physical therapy to maintain mobility.
• Nutritional support to enhance recovery.

Infection Control:

• Standard precautions to prevent infection during treatment.

How to Document Symptoms of Solitary plasmacytoma in relapse (ICD-10 C90.32) in SOAP Notes

Subjective:

• Patient reports localized pain in the affected area.
• History of previous solitary plasmacytoma treatment.
• Complaints of fatigue and weight loss.
• No recent infections or other acute illnesses.

Objective:

• Physical examination reveals tenderness over the tumor site.
• Radiological imaging shows re-emergence of the plasmacytoma.
• Laboratory tests indicate elevated monoclonal protein levels.
• Vital signs stable with no signs of acute distress.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Solitary plasmacytoma in relapse (ICD-10 Code C90.32)

Assessment:

• Diagnosis: Solitary plasmacytoma in relapse, moderate severity.
• ICD-10 Code: C90.32.
• Contributing factors: Previous treatment history and current symptoms.

Plan:

• Initiate radiation therapy targeting the tumor site.
• Schedule follow-up imaging to monitor treatment response.
• Educate the patient on symptom management and potential side effects.
• Arrange for regular follow-up appointments to assess progress.

Treatment & Plan Section for ICD-10 Code C90.32 – Solitary plasmacytoma in relapse

• Consider radiation therapy as first-line treatment.
• Monitor for signs of progression to multiple myeloma.
• Implement supportive care measures to manage symptoms.
• Educate the patient on the importance of follow-up care.

Using ICD-10 Code C90.32 for Solitary plasmacytoma in relapse in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and treatment plans.
• Use C90.32 in appropriate clinical settings for billing.
• Align treatment plans with clinical guidelines to support justified billing.
• Document all relevant findings in the Subjective (S) and Objective (O) sections.

Related ICD-10 Codes Often Used with Solitary plasmacytoma in relapse

• C90.30 – Solitary plasmacytoma of bone, unspecified
• C90.31 – Solitary plasmacytoma of soft tissue
• C90.00 – Multiple myeloma, unspecified
• C90.01 – Multiple myeloma with acute kidney failure

ICD-10 Code C90.32 in Medical Billing and Insurance for Solitary plasmacytoma in relapse

ICD-10 Code C90.32 is critical in medical billing, particularly in hospital, ER, or oncology settings, to ensure accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings to support the use of C90.32.
• Use this code in inpatient and outpatient settings as appropriate.
• Ensure that treatment plans are clearly outlined in the medical record.

Common CPT Pairings: